PT Siloam International Hospitals Tbk (FRA:2LS) ROCE %: 15.78% (As of Mar. 2026)


FRA:2LS PT Siloam International Hospitals Tbk FRA:2LS
91 GF Score
Price €0.10
GF Value €0.13
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Siloam International Hospitals Tbk ROCE %?

PT Siloam International Hospitals Tbk FRA:2LS -3.02% 91 ROCE % is 15.78% as of Mar. 2026. GuruFocus rates FRA:2LS with a GF Score™ of 91/100 and a GF Value™ of €0.13 (Modestly Undervalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PT Siloam International Hospitals Tbk's annualized ROCE % for the quarter that ended in Mar. 2026 was 15.78%.

PT Siloam International Hospitals Tbk  (FRA:2LS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

PT Siloam International Hospitals Tbk ROCE % Related Terms

PT Siloam International Hospitals Tbk ROCE % Historical Data

* Premium members only.

The historical data trend for PT Siloam International Hospitals Tbk's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Siloam International Hospitals Tbk ROCE % Chart

PT Siloam International Hospitals Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.08 13.90 21.36 16.23 15.99

PT Siloam International Hospitals Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.66 13.85 18.68 19.92 15.78
FRA:2LS
91GF Score
PT Siloam International Hospitals Tbk FRA:2LS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Siloam International Hospitals Tbk ROCE % Calculation

PT Siloam International Hospitals Tbk's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=85.251/( ( (846.047 - 303.475) + (741.082 - 217.157) )/ 2 )
=85.251/( (542.572+523.925)/ 2 )
=85.251/533.2485
=15.99 %

PT Siloam International Hospitals Tbk's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=83.78/( ( (741.082 - 217.157) + (783.019 - 244.867) )/ 2 )
=83.78/( ( 523.925 + 538.152 )/ 2 )
=83.78/531.0385
=15.78 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 15.78% mean?
PT Siloam International Hospitals Tbk (FRA:2LS) has a ROCE % of 15.78% as of Mar. 2026.
Is PT Siloam International Hospitals Tbk's ROCE % too high?
PT Siloam International Hospitals Tbk's current ROCE % is 15.78%. The Healthcare Providers & Services industry median ROCE % is 6.41. PT Siloam International Hospitals Tbk's value of 15.78% is 146.2% above this industry median. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's ROCE % compare to HCA and THC?
PT Siloam International Hospitals Tbk's ROCE % of 15.78% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. PT Siloam International Hospitals Tbk's value of 15.78% is 146.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Siloam International Hospitals Tbk's current ROCE % of 15.78% is 146.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Siloam International Hospitals Tbk's current ROCE % is 15.78%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk (FRA:2LS) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.13, compared to a current price of €0.10 — trading 25.8% below its estimated fair value. The current ROCE % is 15.78% and 146.2% above the Healthcare Providers & Services industry median of 6.41. PT Siloam International Hospitals Tbk's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current ROCE % is 15.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued. The current stock price of €0.10 is trading 25.8% below its estimated GF Value™ of €0.13. GuruFocus considers PT Siloam International Hospitals Tbk to be Modestly Undervalued.

Key valuation signals for FRA:2LS:

  • ROCE %: 15.78%
  • GF Value™: €0.13 vs. price of €0.10 (25.8% below fair value)
  • GF Score™: 91/100 with 2 warning signs
  • Industry Position: 146.2% above the Healthcare Providers & Services median

No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Siloam International Hospitals Tbk Business Description

Other Exchanges SILO:Indonesia
Address No. 15, Jalan Boulevard Sudirman, Floor 32, Gedung Fakultas Kedokteran Universitas Pelita Harapan, Lippo Village, Tangerang, IDN, 15810
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
91GF Score

Get the complete analysis for FRA:2LS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.13
GF Value